US$ 25.44
glp 1 drugs pregnancy Scientists cautiously suggest GLP-1s are safe to use around Glucagon-like peptide-1 receptor agonist use
Description
Endocrinology (2022) 163(7):bqac068

Billings, MD, MMSc Billings is the lead author of a Phase 2 clinical trial recently published in the journal Eloralintide is the name of the new medication produced by Eli Lilly and Company that is focused on in this clinical trial

Meta-regression The meta-regression analysis results reveal several insights regarding WL and WR after surgery and also WL after therapy
For the GLP1-RA group, cumulative incidence for live births, pregnancy losses and pregnancy terminations was 59%, 23% and 18%, respectively

These include its single-centre, retrospective design
